Bioconjugates and antibodies for immunodetection assisted by derivatization of the mycotoxin patulin

US12534447B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12534447-B2
Application numberUS-202117800401-A
CountryUS
Kind codeB2
Filing dateFeb 17, 2021
Priority dateFeb 17, 2020
Publication dateJan 27, 2026
Grant dateJan 27, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to bioconjugates and labeled derivatives of the adducts formed by the reaction of patulin with benzene-1,2-dithiols or their salts. Said conjugates are suitable for the production of antibodies capable of recognizing the aforementioned patulin-(benzene-1,2-dithiols) adducts with high affinity and specificity. Likewise, the present invention also relates to the use of bioconjugates of patulin-(benzene-1,2-dithiols) adducts and of labeled derivatives thereof as assay antigens. Furthermore, the present invention also relates to immunochemical methods for the analysis of patulin, using the bioconjugates and labeled derivatives and antibodies of the invention, which include a previous step to quantitatively convert patulin into these adducts. This invention also provides a kit for analyzing patulin comprising a benzene-1,2-dithiol or its salts, antibodies against patulin-(benzene-1,2-dithiols) adducts, and assay antigens.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A bioconjugate of general formula (I): [T-L-Z] m —P  (I) where: T is selected from the group consisting of the radicals R-I and R-II wherein R 1 , R 2 , R 3 , and R 4 are independently selected from H, substituted or unsubstituted aryl groups, linear or branched alkyl groups of 1 to 6 carbon atoms, OMe, OEt, OPr, C≡N, CO 2 H, CO 2 -alkyl of 1 to 6 carbon atoms, NO 2 , NH 2 , F, Cl, Br, and I L is a hydrocarbon chain, saturated or unsaturated, of 0 to 14 carbon atoms, where the chain is linear or branched, and said hydrocarbon chain comprises the substitution of between 0 and 7 carbon atoms by heteroatoms, which are selected from the group consisting of S, O and N, Z is a functional group selected from: —NH—, —NH(C═O)—, —NH(C═O)O—, —(C═O)NH—, —(C═O)O—, —O(C═O)—, —O(C═O)O—, —O(C═O)NH—, —S—, P is a natural or synthetic peptide or polypeptide, or a protein, with a molecular weight greater than 2000 daltons, m is a number with a value between 1 and 500. 2 . The bioconjugate of formula (I) according to claim 1 wherein L is a linear hydrocarbon chain of 0 to 7 carbon atoms and said hydrocarbon chain comprises the substitution of between 0 and 3 carbon atoms by heteroatoms selected from the group consisting of O and N. 3 . The bioconjugate of formula (I) according to claim 1 , characterized in that Z is selected from the group consisting of: —NH—, —NH(C═O)—, —(C═O)NH—, 4 . The bioconjugate of formula (I) according to claim 1 characterized in that L is a linear hydrocarbon chain of 0 to 3 carbon atoms and said hydrocarbon chain comprises the substitution of between 0 and 2 carbon atoms by heteroatoms selected from the group consisting of O and N. 5 . The bioconjugate of formula (I) according to claim 1 characterized in that Z is —(C═O)NH—. 6 . The bioconjugate of formula (I) according to claim 1 , characterized in that P is selected from the group consisting of albumin, thyroglobulin, hemocyanin, beta-galactosidase, phosphatase, peroxidase, and oxidase. 7 . The bioconjugate of formula (I) according to claim 1 , characterized in that m is a number with a value between 1 and 50. 8 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ia) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 9 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ib) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 10 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ic) where P is selected from the group consisting of albumin or peroxidase, m is a value selected between 1 and 50, and where R 2 is CH 3 and R 3 is H, or R 2 is H and R 3 is CH 3 . 11 . The bioconjugate of formula (I) according to claim 1 , having the formula (Id) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 12 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ie) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 13 . The bioconjugate of formula (I) according to claim 1 , having the formula (If) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50, and where R 2 is CH 3 and R 3 is H, or R 2 is H and R 3 is CH 3 . 14 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ig) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 15 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ih) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 16 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ii) where P is selected from the group consisting of albumin or peroxidase, m is a value selected between 1 and 50, and where R 2 is CH 3 and R 3 is H, or R 2 is H and R 3 is CH 3 . 17 . A labeled derivative of formula (II): [T-L-Z] n -Q  (II) wherein, T and L have been defined according to claim 1 ; Z has been defined in claim 1 ; Q is a detectable label and n is a number with a value between 1 and 500. 18 . The labeled derivative of formula (II) according to claim 17 , where Q is selected from the group consisting of enzymes, biotin, fluorescein or any one of its derivatives, a cyanine fluorophore, a rhodamine fluorophore, a coumarin fluorophore, a ruthenium bipyryl, luciferin or any one of its derivatives, an acridinium ester, quantum nanoparticles (quantum dots), and micro- or nanoparticles of colloidal gold, carbon, or latex. 19 . The labeled derivative of formula (II) according to claim 17 characterized in that Z is selected from the group consisting of —NH—, —NH(C═O)—, —(C═O)NH—, 20 . The bioconjugate of formula (II) according to claim 17 , characterized in that m is a number with a value between 1 and 50. 21 . The labeled derivative of formula (II) according to claim 17 , having the formula (IIa) where Q is selected from the group consisting of peroxidase, biotin, fluorescein, or gold nanoparticles, and n is a value selected between 1 and 10. 22 . The labeled derivative of formula (II) according to claim 17 , having the formula (IIb) where Q is selected from the group consisting of peroxidase, biotin, fluorescein, or gold nanoparticles, and n is a value selected between 1 and 10. 23 . The labeled derivative of formula (II) according to claim 17 , having the formula (IIc)

Assignees

Inventors

Classifications

  • Fruits or vegetables · CPC title

  • against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids} · CPC title

  • C07D339/08Primary

    Six-membered rings · CPC title

  • involving hydrolase · CPC title

  • involving oxidoreductase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12534447B2 cover?
The present invention relates to bioconjugates and labeled derivatives of the adducts formed by the reaction of patulin with benzene-1,2-dithiols or their salts. Said conjugates are suitable for the production of antibodies capable of recognizing the aforementioned patulin-(benzene-1,2-dithiols) adducts with high affinity and specificity. Likewise, the present invention also relates to the use …
Who is the assignee on this patent?
Consejo Superior Investigacion, Univ Valencia
What technology area does this patent fall under?
Primary CPC classification C07D339/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).